Search Results - "Isola, Luis M."

Significant Improvement in Survival After Allogeneic Hematopoietic Cell Transplantation During a Period of Significantly Increased Use, Older Recipient Age, and Use of Unrelated Donors by HAHN, Theresa, MCCARTHY, Philip L, LOBERIZA, Fausto, MAZIARZ, Richard T, RIZZO, J. Douglas, JOFFE, Steven, PARSONS, Susan, MAJHAIL, Navneet S, HASSEBROEK, Anna, BREDESON, Christopher, GAJEWSKI, James L, HALE, Gregory A, ISOLA, Luis M, LAZARUS, Hillard M, LEE, Stephanie J, LEMAISTRE, Charles F

“…Over the past four decades, allogeneic hematopoietic cell transplantation (alloHCT) has evolved as a curative modality for patients with hematologic diseases…”
Get full text

Identification of a radio-resistant and cycling dermal dendritic cell population in mice and men by Bogunovic, Milena, Ginhoux, Florent, Wagers, Amy, Loubeau, Martine, Isola, Luis M, Lubrano, Lauren, Najfeld, Vesna, Phelps, Robert G, Grosskreutz, Celia, Scigliano, Eilleen, Frenette, Paul S, Merad, Miriam

“…In this study, we explored dermal dendritic cell (DC) homeostasis in mice and humans both in the steady state and after hematopoietic cell transplantation. We…”
Get full text

Impact of Chronic Graft-versus-Host Disease on Late Relapse and Survival on 7,489 Patients after Myeloablative Allogeneic Hematopoietic Cell Transplantation for Leukemia by Boyiadzis, Michael, Arora, Mukta, Klein, John P, Hassebroek, Anna, Hemmer, Michael, Urbano-Ispizua, Alvaro, Antin, Joseph H, Bolwell, Brian J, Cahn, Jean-Yves Y, Cairo, Mitchell S, Cutler, Corey S, Flowers, Mary E, Gale, Robert P, Herzig, Roger, Isola, Luis M, Jacobsohn, David A, Jagasia, Madan H, Klumpp, Thomas R, Lee, Stephanie J, Petersdorf, Effie W, Santarone, Stella, Spellman, Stephen R, Schouten, Harry C, Verdonck, Leo F, Wingard, John R, Weisdorf, Daniel J, Horowitz, Mary M, Pavletic, Steven Z

“…Malignancy relapse remains a major obstacle for successful allogeneic hematopoietic cell transplantation (HCT). Chronic graft-versus-host disease (cGVHD) is…”
Get full text

Conditioning regimens for allotransplants for diffuse large B-cell lymphoma: myeloablative or reduced intensity? by Bacher, Ulrike, Klyuchnikov, Evgeny, Le-Rademacher, Jennifer, Carreras, Jeanette, Armand, Philippe, Bishop, Michael R., Bredeson, Christopher N., Cairo, Mitchell S., Fenske, Timothy S., Freytes, Cesar O., Gale, Robert Peter, Gibson, John, Isola, Luis M., Inwards, David J., Laport, Ginna G., Lazarus, Hillard M., Maziarz, Richard T., Wiernik, Peter H., Schouten, Harry C., Slavin, Shimon, Smith, Sonali M., Vose, Julie M., Waller, Edmund K., Hari, Parameswaran N.

“…The best conditioning regimen before allogeneic transplantation for high-risk diffuse large B-cell lymphoma (DLBCL) remains to be clarified. We analyzed data…”
Get full text

Prospective study of mobilization kinetics up to 18 hours after late-afternoon dosing of plerixafor by Shi, Patricia A., Miller, Lorraine K., Isola, Luis M.

“…Background The current FDA‐approved time interval between plerixafor dosing and apheresis initiation is approximately 11 hours, but this time interval is…”
Get full text

Severe post-treatment leukopenia associated with the development of encephalopathy following ifosfamide infusion by Kim, Sara S, Isola, Luis M, Oh, William K

“…Ifosfamide has been shown to be associated with encephalopathy in 10–40% of patients. Although it is a well-documented toxicity associated with ifosfamide…”
Get full text

Effect of body mass in children with hematologic malignancies undergoing allogeneic bone marrow transplantation by Aplenc, Richard, Zhang, Mei-Jie, Sung, Lillian, Zhu, Xiaochun, Ho, Vincent T., Cooke, Kenneth, Dvorak, Christopher, Hale, Gregory, Isola, Luis M., Lazarus, Hillard M., McCarthy, Philip L., Olsson, Richard, Pulsipher, Michael, Pasquini, Marcelo C., Bunin, Nancy

“…The rising incidence of pediatric obesity may significantly affect bone marrow transplantation (BMT) outcomes. We analyzed outcomes in 3687 children worldwide…”
Get full text

A case of syngeneic graft-versus-host disease by Patel, Sweta U, Yum, Kendra, Kim, Sara, Isola, Luis M, Scigliano, Eileen, Jakubowski, Rita, Park, Doyun

“…Graft-versus-host disease has been reported to occur rarely in syngeneic hematopoietic stem cell transplant recipients. Clinical and histological changes…”
Get full text

Adverse drug reaction: pomalidomide-induced liver injury by Veluswamy, Rajwanth R, Ward, Stephen C, Yum, Kendra, Abramovitz, Rebecca B, Isola, Luis M, Jagannath, Sundar, Parekh, Samir

“…Survival after multiple myeloma has improved with the use of immunomodulatory drugs--thalidomide, lenalidomide, and pomalidomide. Pomalidomide, the latest…”
Get full text

Estimating cost implications of potentially avoidable hospitalizations among oncology care model patients with prostate cancer by Smith, William H., Parikh, Anish B., Li, Lihua, Sanderson, Mark, Liu, Mark, Mazumdar, Madhu, Isola, Luis M., Dharmarajan, Kavita V.

“…•Potentially avoidable hospitalizations (PAH) represent a cost savings opportunity.•Unavoidable hospitalizations were more costly than PAHs.•PAHs accounted for…”
Get full text

Risk factors associated with increased nonrelapse mortality and with poor overall survival in children with chronic graft-versus-host disease by Jacobsohn, David A., Arora, Mukta, Klein, John P., Hassebroek, Anna, Flowers, Mary E., Cutler, Corey S., Urbano-Ispizua, Alvaro, Bolwell, Brian J., Antin, Joseph H., Boyiadzis, Michael, Cahn, Jean-Yves, Cairo, Mitchell S., Herzig, Roger H., Isola, Luis M., Klumpp, Thomas R., Lee, Stephanie J., Petersdorf, Effie W., Santarone, Stella, Gale, Robert P., Schouten, Harry C., Spellman, Stephen R., Weisdorf, Daniel J., Wingard, John R., Horowitz, Mary M., Pavletic, Steven Z.

“…There is a paucity of information regarding the factors that affect nonrelapse mortality (NRM) and overall survival among children that develop chronic…”
Get full text

Autologous haematopoietic cell transplantation for non‐Hodgkin lymphoma with secondary CNS involvement by Maziarz, Richard T., Wang, Zhiwei, Zhang, Mei‐Jie, Bolwell, Brian J., Chen, Andy I., Fenske, Timothy S., Freytes, Cesar O., Gale, Robert P., Gibson, John, Hayes‐Lattin, Brandon M., Holmberg, Leona, Inwards, David J., Isola, Luis M., Khoury, Hanna J., Lewis, Victor A., Maharaj, Dipnarine, Munker, Reinhold, Phillips, Gordon L., Rizzieri, David A., Rowlings, Philip A., Saber, Wael, Satwani, Prakash, Waller, Edmund K., Maloney, David G., Montoto, Silvia, Laport, Ginna G., Vose, Julie M., Lazarus, Hillard M., Hari, Parameswaran N.

“…Summary Pre‐existing central nervous system (CNS) involvement may influence referral for autologous haematopoietic cell transplantation (AHCT) for patients…”
Get full text

Unrelated donor transplants in adults with Philadelphia-negative acute lymphoblastic leukemia in first complete remission by Marks, David I., Pérez, Waleska S., He, Wensheng, Zhang, Mei-Jie, Bishop, Michael R., Bolwell, Brian J., Bredeson, Christopher N., Copelan, Edward A., Gale, Robert Peter, Gupta, Vikas, Hale, Gregory A., Isola, Luis M., Jakubowski, Ann A., Keating, Armand, Klumpp, Thomas R., Lazarus, Hillard M., Liesveld, Jane L., Maziarz, Richard T., McCarthy, Philip L., Sabloff, Mitchell, Schiller, Gary, Sierra, Jorge, Tallman, Martin S., Waller, Edmund K., Wiernik, Peter H., Weisdorf, Daniel J.

“…We report the retrospective outcomes of unrelated donor (URD) transplants in 169 patients with acute lymphoblastic leukemia (ALL) in first complete remission…”
Get full text

Prospective cohort study of the circadian rhythm pattern in allogeneic sibling donors undergoing standard granulocyte colony-stimulating factor mobilization by Shi, Patricia A, Isola, Luis M, Gabrilove, Janice L, Moshier, Erin L, Godbold, James H, Miller, Lorraine K, Frenette, Paul S

“…Prior in vivo murine studies suggest circadian oscillations for hematopoietic stem cell release, which are maintained following administration of granulocyte…”
Get full text

A case report of concomitant paroxysmal nocturnal hemoglobinuria and sickle cell disease by Carreiro, Jennifer M., Strauchen, James A., Isola, Luis M.

Get full text

Uptake of Long Chain Free Fatty Acids Is Selectively Up-regulated in Adipocytes of Zucker Rats with Genetic Obesity and Non-insulin-dependent Diabetes Mellitus by Berk, Paul D., Zhou, Sheng-Li, Kiang, Chih-Li, Stump, Decherd, Bradbury, Michael, Isola, Luis M.

“…To examine whether fatty acid transport is abnormal in obesity, the kinetics of [3H]oleate uptake by hepatocytes, cardiac myocytes, and adipocytes from adult…”
Get full text

Classifying Cytogenetics in Patients with Acute Myelogenous Leukemia in Complete Remission Undergoing Allogeneic Transplantation: A Center for International Blood and Marrow Transplant Research Study by Armand, Philippe, Kim, Haesook T, Zhang, Mei-Jie, Perez, Waleska S, Dal Cin, Paola S, Klumpp, Thomas R, Waller, Edmund K, Litzow, Mark R, Liesveld, Jane L, Lazarus, Hillard M, Artz, Andrew S, Gupta, Vikas, Savani, Bipin N, McCarthy, Philip L, Cahn, Jean-Yves, Schouten, Harry C, Finke, Jürgen, Ball, Edward D, Aljurf, Mahmoud D, Cutler, Corey S, Rowe, Jacob M, Antin, Joseph H, Isola, Luis M, Di Bartolomeo, Paolo, Camitta, Bruce M, Miller, Alan M, Cairo, Mitchell S, Stockerl-Goldstein, Keith, Sierra, Jorge, Savoie, M. Lynn, Halter, Joerg, Stiff, Patrick J, Nabhan, Chadi, Jakubowski, Ann A, Bunjes, Donald W, Petersdorf, Effie W, Devine, Steven M, Maziarz, Richard T, Bornhauser, Martin, Lewis, Victor A, Marks, David I, Bredeson, Christopher N, Soiffer, Robert J, Weisdorf, Daniel J

“…Cytogenetics play a major role in determining the prognosis of patients with acute myelogenous leukemia (AML). However, existing cytogenetics classifications…”
Get full text

Center for International Blood and Marrow Transplant Research Chronic Graft-versus-Host Disease Risk Score Predicts Mortality in an Independent Validation Cohort by Arora, Mukta, Hemmer, Michael T, Ahn, Kwang Woo, Klein, John P, Cutler, Corey S, Urbano-Ispizua, Alvaro, Couriel, Daniel R, Alousi, Amin M, Gale, Robert Peter, Inamoto, Yoshihiro, Weisdorf, Daniel J, Li, Peigang, Antin, Joseph H, Bolwell, Brian J, Boyiadzis, Michael, Cahn, Jean-Yves, Cairo, Mitchell S, Isola, Luis M, Jacobsohn, David A, Jagasia, Madan, Klumpp, Thomas R, Petersdorf, Effie W, Santarone, Stella, Schouten, Harry C, Wingard, John R, Spellman, Stephen R, Pavletic, Steven Z, Lee, Stephanie J, Horowitz, Mary M, Flowers, Mary E.D

“…Abstract We previously reported a risk score that predicted mortality in patients with chronic graft-versus-host disease (CGVHD) after hematopoietic stem cell…”
Get full text

Influence of Pomalidomide and Lenalidomide on Total Cost of Care for Medicare Beneficiaries with Multiple Myeloma Under the Oncology Care Model (OCM) by Theroux, Haley Hines, Isola, Luis M, Liu, Mark, Williams, Alaysia

“…Background: In July of 2016, CMMI started a five year bundled payment program called OCM. Beneficiaries are attributed to practices providing their cancer care…”
Get full text

Minimizing prostate cancer admissions via enhanced outpatient care: A model for savings by Parikh, Anish, Sanderson, Mark, Isola, Luis M., Ennis, Ronald D.

“…Abstract only 46 Background: Hospitalization is a major contributor to cost in oncology. Minimizing avoidable admissions can lead to substantial savings…”
Get full text